The relative proportion of comorbidities among rhinitis and rhinosinusitis patients and their impact on visit burden.

Authors:
Nuutinen M; Lyly A; Virkkula P; Hytönen M; Saarentaus E and 5 more

Journal:
Clin Transl Allergy

Publication Year: 2022

DOI:
10.1002/clt2.12181

PMCID:
PMC9301683

PMID:
35874969

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Clin Transl Allergy

Abbreviation: Clin Transl Allergy

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A cross talk between microbial metabolites and host immunity: Its relevance for allergic diseases.
Losol P; Wolska M; Wypych TP and 3 more (2024) - Transparency Score: 3/6
Bacteria and viruses and clinical outcomes of asthma-bronchiectasis overlap syndrome: A cohort stud…
Zhang XX; He JH; Pan CX and 8 more (2024) - Transparency Score: 3/6
Characteristics of mucin hypersecretion in different inflammatory patterns based on endotypes of ch…
Zhai Z; Shao L; Lu Z and 8 more (2024) - Transparency Score: 3/6
Chronic spontaneous urticaria: Evidence of systemic microcirculatory changes.
Mostmans Y; Maurer M; Richert B and 6 more (2024) - Transparency Score: 4/6
Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune.
Oguma T; Ishiguro T; Kamei K and 33 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTERESTS Sanna Toppila‐Salmi report consultancies for ALK‐Abelló, AstraZeneca, ERT, GlaxoSmithKline, Novartis, Sanofi, Roche Products, and a grant from GlaxoSmithKline. Annina Lyly reports consultancies for Viatris, Novartis and Sanofi. Paula Virkkula reports consultancies for Sanofi and GlaxoSmithKline. All are outside the submitted work. All other authors declare no conflicts of interest."

Evidence found in paper:

"The study was supported in part by research grants from the Finnish Society of Allergology and Immunology, the Jane and Aatos Erkko Foundation, Paulo Foundation, State funding for university‐level health research (TYH2019322), the Tampere Tuberculosis Foundation, and the Väinö and Laina Kivi Foundation."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025